Risk of Anogenital Warts in Renal Transplant Recipients Compared with Immunocompetent Controls: A Cross-sectional Clinical Study

Authors

  • Helle K. Larsen Department of Dermato-Venereology, Bispebjerg Hospital, DK-2400 Copenhagen, Denmark
  • Louise T. Thomsen
  • Merete Hædersdal
  • Trine Thorborg Lok
  • Jesper Melchior Hansen
  • Søren Schwartz Sørensen
  • Susanne K. Kjær

DOI:

https://doi.org/10.2340/00015555-3858

Keywords:

renal transplant recipients, anogenital warts, human papillomavirus, cross-sectional study

Abstract

Renal transplant recipients have increased risk of human papilloma virus-related anogenital (pre)cancers. Less is known about their risk of anogenital warts. The aim of this study was to estimate the prevalence and odds of anogenital warts in renal transplant recipients compared with immunocompetent controls, and to assess risk factors for intra- and perianal warts in renal transplant recipients. The study examined 248 renal transplant recipients and 250 controls for cutaneous and mucosal anogenital warts. Participants completed a questionnaire on lifestyle and sexual habits. For external anogenital warts (including penile, vulvar and perianal warts), renal transplant recipients had higher prevalence and odds than controls, both in men (8.1% vs 1.6%, adjusted odds ratio (ORadjusted)=5.09, 95% confidence interval (95% CI), 1.03–25.04) and women (11.3% vs 1.6%, ORadjusted=8.09, 95% CI 1.69–38.82). For intra-anal warts, there was no clear pattern of higher odds in renal transplant recipients than controls. Current smoking and having had receptive anal sex increased the risk of intra-/perianal warts in renal transplant recipients. In conclusion, renal transplant recipients in this study had higher odds of external anogenital warts than controls.

Downloads

Download data is not yet available.

References

Voora S, Adey D. Management of kidney transplant recipients by general nephrologists: core curriculum 2019. Am J Kidney Dis 2019; 76: 866–879.

Skov Dalgaard L, Fassel U, Østergaard LJ, Jespersen B, Søgaard OS, Jensen-Fangel S. Risk of human papillomavirus-related cancers among kidney transplant recipients and patients receiving chronic dialysis – an observational cohort study. BMC Nephrol 2013; 14: 137.

Reinholdt K, Thomsen LT, Dehlendorff C, Larsen HK, Sørensen SS, Haedersdal M, et al. Human papillomavirus-related anogenital premalignancies and cancer in renal transplant recipients: a Danish nationwide, registry-based cohort study. Int J Cancer 2020; 146: 2413–2422.

Madeleine MM, Finch JL, Lynch CF, Goodman MT, Engels EA. HPV-related cancers after solid organ transplantation in the United States. Am J Transplant 2013; 13: 3202–3209.

Zachariae C, Sand C, Hansen JM, Sørensen SS, Koch K, Villumsen J, et al. Warts in a cohort of Danish kidney transplanted patients: impact on quality of life. Acta Derm Venereol 2012; 92: 615–618.

Giuliano AR, Tortolero-Luna G, Ferrer E, Burchell AN, de Sanjose S, Kjaer SK, et al. Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions. Vaccine 2008; 26: K17–28.

Bollerup S, Baldur-Felskov B, Blomberg M, Baandrup L, Dehlendorff C, Kjaer SK. Significant reduction in the incidence of genital warts in young men 5 years into the danish human papillomavirus vaccination program for girls and women. Sex Transm Dis 2016; 43: 238–242.

Drolet M, Bénard E, Pérez N, Brisson M; HPV Vaccination Impact Study Group. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis. The Lancet 2019; 394: 497–509.

Larsen HK, Hædersdal M, Thomsen LT, Hertzum-Larsen R, Lok TT, Bonde J, et al. Risk of anal high-grade squamous intraepithelial lesions among renal transplant recipients compared with immunocompetent controls. Clin Infect Dis 2021; 73: 21–29.

Blomberg M, Friis S, Munk C, Bautz A, Kjaer SK. Genital warts and risk of cancer: a Danish study of nearly 50 000 patients with genital warts. J Infect Dis 2012; 205: 1544–1553.

Cho CY, Lo YC, Hung MC, Lai CC, Chen CJ, Wu KG. Risk of cancer in patients with genital warts: a nationwide, population-based cohort study in Thaiwan. PLoS One 2017; 12: e0183183.

Azevedo J, Pista A, Lisboa C, Santo I, Azevedo L, Cunha MJ, HERCOLES Study Group. Epidemiology of human papillomavirus on anogenital warts in Portugal – the HERCOLES study. J Eur Acad Dermatol Venereol 2017; 31: 1342–1348.

Brown DR, Schroeder JM, Bryan JT, Stoler MH, Fife KH. Detection of multiple human papillomavirus types in condylomata acuminata lesions from otherwise healthy and immunosuppressed patients. J Clin Microbiol 1999; 37: 3316–3322.

Kjaer SK, van den Brule AJ, Bock JE, Poll PA, Engholm G, Sherman ME, et al. Determinants for genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal Pap smear: are there different risk profiles for oncogenic and nononcogenic HPV types? Cancer Epidemiol Biomarkers Prev 1997; 6: 799–805.

Larsen HK, Thomsen LT, Haedersdal M, Dehlendorff C, Schwartz Sørensen S, Kjaer SK. Risk of genital warts in renal transplant recipients – a registry-based, prospective cohort study. Am J Transplant 2019; 19: 156–165.

Ogunbiyi OA, Scholefield JH, Raftery AT, Smith JH, Duffy S, Sharp F, et al. Prevalence of anal human papillomavirus infection and intraepithelial neoplasia in renal allograft recipients. Br J Surg 1994; 81: 365–367.

Rüdlinger R, Smith IW, Bunney MH, Hunter JA. Human papillomavirus infections in a group of renal transplant recipients. Br J Dermatol 1986; 115: 681–692.

Euvrard S, Kanitakis J, Chardonnet Y, Noble CP, Touraine JL, Faure M, et al. External ano-genital lesions in organ transplant recipients. A clinicopathologic and virologic assessment. Arch Dermatol 1997; 132: 175–178.

Nadhan KS, Larijani M, Abbott J, Doyle AM, Linfante AW, Chung CL. Prevalence and Types of Genital Lesions in Organ Transplant Recipients. JAMA Dermatol 2018; 154: 323–329.

Alimagham M, Amini-Afshar S, Farahmand S, Pour-Kazemi A, Pour-Reza-Gholi F, Masood S. Frequency of infectious skin lesions in kidney transplant recipients. Urol J 2005; 2: 193–196.

Heaf J. The Danish Nephrology Registry. Clin Epidemiol 2016; 8: 621–627.

Chow EP, Lin AC, Read TR, Bradshaw CS, Chen MY, Fairley CK. Ratio of anogenital warts between different anatomical sites in homosexual and heterosexual individuals in Australia, 2002-2013: implications for susceptibility of different anatomical sites to genital warts. Epidemiol Infect 2015; 143: 1495–1499.

Jin F, Prestage GP, Kippax SC, Pell CM, Donovan B, Templeton DJ, et al. Risk factors for genital and anal warts in a prospective cohort of HIV-negative homosexual men: the HIM study. Sex Transm Dis 2007; 34: 488–493.

Stanley MA, Sterling JC. Host responses to infection with human papillomavirus. Curr Probl Dermatol 2014; 45: 58–74.

Workowski KA, Bolan GA. Centers for Disease Control and Prevention. Sexually Transmitted Disease Treatment Guidelines 2015. Human papillomavirus infection. MMWR Recomm Rep 2015; 64: 85.

Faber MT, Kjaer AK, Larsen HK, Thomsen LT, Haedersdal M, Bonde J, et al. Prevalence, type distribution and risk factors for oral HPV in Danish renal transplant recipients. Oral Dis 2020; 26: 484–488.

Anic GM, Lee JH, Villa LL, Lazcano-Ponce E, Gage C, José C Silva R, et al. Risk factors for incident condyloma in a multinational cohort of men: the HIM study. J Infect Dis 2012; 205: 798–793.

Kaderli R, Schnuriger B, Brugger LE. The impact of smoking on HPV infection and the development of anogenital warts. Int J Colorectal Dis 2014; 29: 899–908.

Giuliano AR, Sirak B, Abrahamsen M, Silva RJC, Baggio ML, Galan L, et al. Genital Wart Recurrence Among Men Residing in Brazil, Mexico, and the United States. J Infect Dis 2019; 219: 703–710.

Larsen HK, Banzhaf CA, Thomsen SF, Gormsen M, Schopf RE, Haedersdal M. An exploratory, prospective, open-label trial of ingenol mebutate gel 0.05% for the treatment of external anogenital warts. J Eur Acad Dermatol Venereol 2018; 32: 825–831.

The Danish Nephrology Registry: Annual report 2017 (in Danish). Odense: Danish Nephrology register, 2017.

[accessed 5 March 2021]. Available from: https://nephrology.dk/wp-content/uploads/2018/10/Aarsrapport-2017.pdf/.

Engberg H, Wehberg S, Bistrup C, Heaf J, Sørensen SS, Thiesson HC, et al. Cancer risk and mortality after kidney transplantation: a population-based study on differences between Danish centres using standard immunosuppression with and without glucocorticoids. Nephrol Dial Transplant 2016; 31: 2149–2156.

Kjaer SK, Tran TN, Sparen P, Tryggvadottir L, Munk C, Dasbach E, et al. The burden of genital warts: a study of nearly 70,000 women from the general female population in the 4 Nordic countries. J Infect Dis 2007; 196: 1447–1454.

Patel H, Wagner M, Singhal P, Kothari S. Systematic review of the incidence and prevalence of genital warts. BMC Infect Dis 2013; 13: 39.

Hillman RJ, Cuming T, Darragh T, Nathan M, Berry-Lawthorn M, Goldstone S, et al. 2016 IANS International Guidelines for practice standards in the detection of anal cancer precursors. J Low Genit Tract Dis 2016; 20: 283–291.

Chin-Hong PV, Reid GE, AST Infectious Diseases Community of Practice. Human papillomavirus infection in solid organ transplant recipients: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 2019; 33: e13590.

Published

2021-07-13

How to Cite

Larsen, H. K., Thomsen, L. T., Hædersdal, M., Lok, T. T., Hansen, J. M., Sørensen, S. S., & Kjær, S. K. (2021). Risk of Anogenital Warts in Renal Transplant Recipients Compared with Immunocompetent Controls: A Cross-sectional Clinical Study. Acta Dermato-Venereologica, 101(7), adv00497. https://doi.org/10.2340/00015555-3858